- Previous Close
0.0300 - Open
0.0350 - Bid 0.0270 x --
- Ask 0.0300 x --
- Day's Range
0.0300 - 0.0350 - 52 Week Range
0.0120 - 0.0500 - Volume
1,348,631 - Avg. Volume
235,639 - Market Cap (intraday)
10.997M - Beta (5Y Monthly) 0.03
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
HITIQ Limited, together with its subsidiaries, engages in development and commercialization of concussion management technology and software in Australia. The company offers Smart Mouthguard, a mouthguard embedded with sensor technology to measure head impact events; and Nexus, a calibrated mouthguard with impact sensors that captures the frequency, location, and intensity of head impact exposures. It also provides CSX platform, a sideline concussion assessment tool that produces a digital record that can be shared with medical professionals, family, and organizations to ensure coordinated athlete care; CoVR, a virtual reality based cognitive and oculomotor assessment platform; and ConneQt, an integrated ecosystem linking team administrators, caregivers, and players to medical professionals. The company serves the Australian Football League, English Premier League, and the National Rugby League; various sporting teams; and universities and research organizations studying the impacts of repeat head impacts. HITIQ Limited was incorporated in 2015 and is headquartered in South Melbourne, Australia.
www.hitiq.com25
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: HIQ.AX
View MorePerformance Overview: HIQ.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HIQ.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HIQ.AX
View MoreValuation Measures
Market Cap
11.00M
Enterprise Value
14.93M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.05
Price/Book (mrq)
--
Enterprise Value/Revenue
13.29
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-141.21%
Return on Assets (ttm)
-93.22%
Return on Equity (ttm)
--
Revenue (ttm)
3.37M
Net Income Avi to Common (ttm)
-4.75M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
661k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-4.79M